Neha Patil (Editor)

Stratec Biomedical Systems

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
ISIN
  
DE000STRA555

Number of employees
  
~ 950

Headquarters
  
Birkenfeld, Germany

Subsidiaries
  
STRATEC Services AG

Revenue
  
~ € 180 million (2016)

Website
  
stratec.com

Founded
  
1979

Stratec Biomedical Systems wwwrobionchimageslogogif

Key people
  
Marcus Wolfinger (CEO), Dr. Robert Siegle, Dr. Claus Vielsack

Products
  
World leading partner for development and manufacturing of technological and scientific solutions for the life science industry.

Stock price
  
STRA55 (ETR) € 55.90 +1.81 (+3.35%)28 Mar, 5:36 PM GMT+2 - Disclaimer

STRATEC Biomedical AG is a company with worldwide operations that develops and produces analyzer systems and automation systems in the field of in-vitro-diagnostics. As a classic OEM (Original Equipment Manufacturer) supplier, STRATEC produces its systems almost exclusively on behalf of its customers. Alongside the systems themselves, the company also develops system software solutions and software to connect the systems to laboratory software (Middleware). Stratec is also responsible for development documentation, testing and delivering the systems, and supplying spare parts and consumables. STRATEC's customers are well known diagnostic companies like SIEMENS, Bio-Rad or Hologic.

Contents

Locations

Since its foundation, the company's headquarters has been in Birkenfeld in Enzkreis district, Gräfenhausen neighborhood. The company also has several branches and development and production sites:

History

The company was founded in Birkenfeld in 1979. Stratec Biomedical AG was publicly listed (IPO) in 1998. The wholly owned subsidiary Robion AG was founded in Switzerland in 2005 and later renamed as Stratec Biomedical Switzerland AG. Sanguin International, Ltd., UK, was acquired in 2006 and renamed as Stratec Biomedical UK, Ltd. This was followed in 2009 by the acquisition of Invitek Gesellschaft für Biotechnik & Biodesign mbH, Berlin, now Stratec Molecular GmbH, and of Ballista, Inc., USA, now Stratec Biomedical USA, Inc. in 2010. In November 2010, the company was admitted into the TecDAX stock market index. In March 2016 STRATEC acquired the Hungary-based company Diatron, a hematology system specialist. The company develops and manufactures analyzer systems and complementary products for use in human and veterinary diagnostics. In June 2016 another acquisition was announced: Sony DADC Biosciences GmbH, headquartered in Anif, Austria. The Company has about 120 employees and is an OEM-supplier for smart consumable for diagnostics and life sciences applications.

References

Stratec Biomedical Systems Wikipedia